Keith Speights
TMFFishBiz
Keith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.
Recent Articles by Keith Speights

Jun 20, 2025
by Keith Speights
Where Will Amazon Stock Be in 5 Years?

Jun 18, 2025
by Keith Speights
Best Stock to Buy Right Now: Amazon vs. Apple

Jun 17, 2025
by Keith Speights
The Stock Is Up Almost 56,000% and Is Still a Buy

Jun 17, 2025
by Keith Speights
Why Verve Therapeutics Stock Is Skyrocketing Today
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.